BERKELEY, CALIFORNIA / ACCESS Newswire / February 4, 2025 / Heliospace, a subsidiary of Helio Corporation (OTC PINK:HLEO) has announced the ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

If we're being frank, which is how we roll in the Rocket Report, some of Orbex's recent activity does not inspire confidence.